Uneoth.com

The News Source You've Been Waiting For

Medicine

Evaluate Purchases J+D Forecasting

Acquisition is expected to offer life sciences clients a boost in expertise and insight.

Evaluate, who is not only a Norstella company, but also a consulting and forecasting source of data and insight for the life sciences sector, has acquired J+D Forecasting, a provider of forecasting solutions for the pharmaceutical industry.

The company noted that global pharma industry is undergoing a period of change and uncertainty, due in part to changes in legislation and regulation, the current geopolitical environment, and patent expiration. Therefore, the ability to accurately determine forecast market size, spot growth trends in various categories, and keep up with new technology have become more of a necessity. The combination of Evaluate’s consensus forecasting and consulting knowledge with J+D Forecasting’s specialized models that are delivered via cloud-based management and analytical solutions are expected to assist clients with creating more intelligent and consistent insights, while having the parties combined collaborate throughout the entire process.

“We are delighted to welcome the J+D Forecasting team to the Norstella family. Their expertise in developing bespoke forecasting models and innovative, intuitive solutions will provide our customers with an even wider breadth of expertise and cutting-edge insight,” said Mike Gallup, CEO, Norstella’s CEO. “The addition of these capabilities significantly boosts our ability to help achieve our mission of smoothing the path of life-saving therapies from pipeline to patient.”

Norstella will continue its efforts in expanding its forecasting portfolio by incorporating J+D Forecasting’s models and employing GenAI to synthesize insights from various models, with the goal of designing a “one-stop solution” for all forecasting necessities.

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *